Relevium Technologies Inc. (RLLVF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 3 | 1 | - | - | - | - | 1 | - |
| Operating profit | CAD m | -1 | -3 | ||||||
| Net profit | CAD m | -7 | -5 | - | - | - | - | -7 | - |
| EPS reported | CAD | -0.03 | -0.04 | ||||||
| Operating cashflow per share | CAD | -0.00 | -0.00 | ||||||
| Capex per share | CAD | 0.00 | 0.00 | ||||||
| FCF per share | CAD | -0.00 | -0.00 | ||||||
| Free cash flow | CAD m | -0 | -33 | ||||||
| Net debt | CAD m | 3 | 1 | ||||||
| Book value equity | CAD m | -5 | - | ||||||
| Book value per share | CAD | -0.02 | -0.02 | ||||||
| Number of shares | m | 206.99 | 209.77 | ||||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -0.86 | -0.36 | ||||||
| P/S LTM | x | 4.61 | 3.05 | ||||||
| P/FCF LTM | x | -32.99 | -21.84 | ||||||
| EV/EBITDA LTM | x | -1.59 | -1.28 | ||||||
| EV/Sales LTM | x | 8.03 | 6.48 | ||||||
| Earnings Yield LTM | % | -1.28% | -3.07% | ||||||
| FCF Yield | % | -3.03% | -1201.2% | ||||||
| Quality | |||||||||
| ROE | % | +109.47% | +221.45% | ||||||
| ROIC | % | +88.93% | +88.93% | ||||||
| Operating margin | % | -1.61% | -1.61% | ||||||
| Gross margin | % | +45.37% | +45.37% | ||||||
| FCF/Sales | % | -13.96% | -13.96% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -69.28% | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.04 | -12.81 | ||||||
| Net Debt/EBITDA | x | -0.68 | -0.68 | ||||||
| EBIT/Net interest | x | -1.96 | -1.96 | ||||||
| Net debt/market cap | % | +75.97% | +1.15% | ||||||
| Net debt/Equity | x | -0.64 | - | ||||||
| Gross debt/equity | x | -0.65 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free